Gastrointestinal Tract Cancer Clinical Trial
Official title:
Serum Carotenoids and Risk of Gastrointestinal Tract Cancer: Meta-analysis of Ten Studies
Verified date | February 2018 |
Source | West China Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Previous studies have suggested that serum carotenoids may be associated with risk of gastrointestinal tract cancer (GIT cancer), but the results were inconsistent. Thus, the investigators conducted a meta-analysis to evaluate the associations between serum carotenoids and risk of GIT cancer.
Status | Completed |
Enrollment | 40641 |
Est. completion date | December 28, 2017 |
Est. primary completion date | November 20, 2017 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - The study had both case and control groups - Serum carotenoids levels, relative risk (RR) or OR and corresponding 95% CI were reported - Patients in case group were diagnosed with GIT cancer Exclusion Criteria: ·Animal studies |
Country | Name | City | State |
---|---|---|---|
China | West China Hospital, Sichuan University | Chengdu | Sichuan |
Lead Sponsor | Collaborator |
---|---|
Yong Zhou | Sichuan Provincial Science and Technology Support Project (2016SZ0047) |
China,
Huang J, Lu MS, Fang YJ, Xu M, Huang WQ, Pan ZZ, Chen YM, Zhang CX. Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China. Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201700267. Epub 2017 Jul 31. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gastrointestinal Tract Cancer Incident Measure | The gastrointestinal tract cancer incident would be recorded during the follow-up years. | Through study completion, an average of 5 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02428101 -
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
|